The prevalence of autoimmune endocrine diseases in vitiligo patients
- 作者: Troshina E.1, Volnukhin V.2, Petrov V.2, Nuralieva N.1, Yukina M.1, Orlova E.1, Frigo N.2
-
隶属关系:
- Endocrinology Research Centre
- Moscow Research and Practical Center for Dermatovenereology and Cosmetology
- 期: 卷 92, 编号 10 (2020)
- 页面: 88-96
- 栏目: Reviews
- URL: https://journals.rcsi.science/0040-3660/article/view/50988
- DOI: https://doi.org/10.26442/00403660.2020.10.000736
- ID: 50988
如何引用文章
全文:
详细
Vitiligo is a common polygenic autoimmune disease in which the foci of depigmentation are formed on the skin and/or mucous membranes as a result of the death of melanocytes. There are several hypotheses for the pathogenesis of the disease, the leading role among them is played the autoimmune hypothesis. This review summarizes the available literature data on the prevalence and structure of comorbid endocrine autoimmune pathology in vitiligo patients. In most studies conducted in Europe, America and Asia the prevalence of autoimmune thyroid diseases (including autoimmune thyroiditis and Graves disease), diabetes mellitus and autoimmune adrenal insufficiency was higher in vitiligo patients than in the general population. The results of some studies indicate a frequent association of vitiligo with autoimmune polyglandular syndromes. In the structure of comorbid pathology the highest prevalence was in autoimmune thyroid diseases. A number of studies have established a higher prevalence of autoimmune endocrine diseases in women, as well as in nonsegmental vitiligo patients and in cases of family history of vitiligo and/or other autoimmune diseases. In addition, it was shown that the prevalence of endocrine diseases increases with increasing area of depigmentation. The data obtained justify the advisability of conducting a timely examination of vitiligo patients with the aim of early detection of comorbid diseases and the appointment of appropriate treatment. Further studies are needed to investigate the effect of the identified associations on the course of vitiligo and comorbid endocrinopathies, as well as the effectiveness of therapy and the quality of life of patients.
作者简介
E. Troshina
Endocrinology Research Centre
Email: vipe26@mail.ru
ORCID iD: 0000-0002-8520-8702
чл.-кор. РАН, д.м.н., проф., зав. отд. терапевтической эндокринологии ФГБУ «НМИЦ эндокринологии»
俄罗斯联邦, MoscowV. Volnukhin
Moscow Research and Practical Center for Dermatovenereology and Cosmetology
Email: vipe26@mail.ru
ORCID iD: 0000-0002-8363-5188
д.м.н., проф., гл. науч. сотр. отд. научно-прикладных методов исследования ГБУЗ МНПЦДК
俄罗斯联邦, MoscowV. Petrov
Moscow Research and Practical Center for Dermatovenereology and Cosmetology
编辑信件的主要联系方式.
Email: vipe26@mail.ru
ORCID iD: 0000-0002-9706-1920
зав. дерматовенерологическим отд-нием Центрального отдела специализированной медицинской помощи ГБУЗ МНПЦДК
俄罗斯联邦, MoscowN. Nuralieva
Endocrinology Research Centre
Email: vipe26@mail.ru
ORCID iD: 0000-0001-6876-3336
науч. сотр. отд. терапевтической эндокринологии ФГБУ «НМИЦ эндокринологии»
俄罗斯联邦, MoscowM. Yukina
Endocrinology Research Centre
Email: vipe26@mail.ru
ORCID iD: 0000-0002-8771-8300
к.м.н., вед. науч. сотр. отд. терапевтической эндокринологии ФГБУ «НМИЦ эндокринологии»
俄罗斯联邦, MoscowE. Orlova
Endocrinology Research Centre
Email: vipe26@mail.ru
ORCID iD: 0000-0001-6196-5322
д.м.н., доц. каф. детской эндокринологии ИВиДПО, вед. науч. сотр. детского отд-ния опухолей эндокринной системы ФГБУ «НМИЦ эндокринологии»
俄罗斯联邦, MoscowN. Frigo
Moscow Research and Practical Center for Dermatovenereology and Cosmetology
Email: vipe26@mail.ru
ORCID iD: 0000-0001-6231-971X
д.м.н., зам. дир. по науч. работе, рук. отд. научно-прикладных методов исследования ГБУЗ МНПЦДК
俄罗斯联邦, Moscow参考
- Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003 Oct 23;1:58. doi: 10.1186/1477-7525-1-58
- Krüger C, Schallreuter K. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206-12. doi: 10.1111/j.1365-4632.2011.05377.x
- Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74-84. doi: 10.1016/S0140-6736(14)60763-7
- Spritz R, Andersen G. Genetics of vitiligo. Dermatol Clin. 2017;35(2):245-55. doi: 10.1016/j.det.2016.11.013
- Narita T, Oiso N, Fukai K, et al. Generalized vitiligo associated autoimmune diseases in Japanese patients their families. Allergol Int. 2011;60(4):505-8. doi: 10.2332/allergolint.11-OA-0303
- Sheth V, Guo Y, Qureshi A. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227(4):311-5. doi: 10.1159/000354607
- Gill L, Zarbo A, Isedeh P, et al. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016;74(2):295-302. doi: 10.1016/j.jaad.2015.08.063
- Vrijman C, Kroon M, Limpens J, et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol. 2012;167(6):1224-35. doi: 10.1111/j.1365-2133.2012.11198.x
- Yuan J, Sun C, Jiang S, et al. The prevalence of thyroid disorders in patients with vitiligo: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2019;9:803. doi: 10.3389/fendo.2018.00803
- Fan KC, Yang TH, Huang YC. Vitiligo and thyroid disease: a systematic review and meta-analysis. Eur J Dermatol.2018;28(6):750-63. doi: 10.1684/ejd.2018.3449
- Gey A, Diallo A, Seneschal J, et al. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. Br J Dermatol. 2013;168(4):756-61. doi: 10.1111/bjd.12166
- Yazdanpanah MJ, Seyedi Noghabi SA, Taghavi M, et al. Comparison of autoimmune thyroid disease in patients with progressive and stable vitiligo. J Cutan Med Surg. 2016;20(2):135-8. doi: 10.1177/1203475415604551
- Van Geel N, Speeckaert M, Brochez L, et al. Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases. J Eur Acad Dermatol Venereol. 2014;28(6):741-6. doi: 10.1111/jdv.12169
- Chen Y, Chen Y, Hwang C, et al. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2015;29(7):1362-9. doi: 10.1111/jdv.12870
- Teulings HE, Ceylan E, Overcamp M, et al. Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥50 years. Br J Dermatol. 2016;175(4):821. doi: 10.1111/bjd.14640
- Campi I, Salvi M. Graves’ Disease. In: Huhtaniemi I, Martini L, editors. Encyclopedia of Endocrine Diseases. 2nd ed. Elsevier Inc., 2018; p. 698-701.
- Iddah M, Macharia B. Autoimmune thyroid disorders. ISRN Endocrinol. 2013;2013:1-9. doi: 10.1155/2013/509764
- Lazzeri L, Colucci R, Cammi A, et al. Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening. Biomed Res Int. 2016;2016:1-5. doi: 10.1155/2016/8065765
- Nicolaidou E, Antoniou C, Miniati A, et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol. 2012;66(6):954-8. doi: 10.1016/j.jaad.2011.07.010
- Alkhateeb A, Fain P, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families. Pigment Cell Res. 2003;16(3):208-14. doi: 10.1034/j.1600-0749.2003.00032.x
- Laberge G, Mailloux C, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005;18(4):300-5. doi: 10.1111/j.1600-0749.2005.00242.x
- Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol. 2010;24(10):1144-50. doi: 10.1111/j.1468-3083.2010.03605.x
- Birlea SA, Fain PR, Spritz RA. A romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol. 2008;144(3):310-6. doi: 10.1001/archderm.144.3.310
- Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol. 1968;80(3):135-9. doi: 10.1111/j.1365-2133.1968.tb12282.x
- Hegedüs L, Heidenheim M, Gervil M, et al. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol. 1994;74(2):120-3. doi: 10.2340/0001555574120123
- Ingordo V, Cazzaniga S, Raone B, et al. Circulating Aautoantibodies and autoimmune comorbidities in vitiligopatients: a multicenter Italian study. Dermatology. 2014;228(3):240-9. doi: 10.1159/000357807
- Schallreuter K, Lemke R, Brandt O, et al. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology. 1994;188(4):269-75. doi: 10.1159/000247164
- Zettinig G, Tanew A, Fischer G, et al. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?. Clin Exp Immunol. 2003;131(2):347-54. doi: 10.1046/j.1365-2249.2003.02089.x
- Korkij W, Solatani K, Simjee S, et al. Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study. J Cutan Pathol. 1984;11(6):522-30. doi: 10.1111/j.1600-0560.1984.tb00413.x
- Nunes DH, Esser LM. Vitiligo epidemiological profile and the association with thyroid disease. An Bras Dermatol. 2011;86(2):241-8. doi: 10.1590/s0365-05962011000200006
- Sawicki J, Siddha S, Rosen C. Vitiligo and associated autoimmune disease: retrospective review of 300 patients. J Cutan Med Surg. 2012;16(4):261-6. doi: 10.1177/120347541201600408
- Silverberg J, Silverberg N. Clinical features of vitiligo associated with comorbid autoimmune disease: A prospective survey. J Am Acad Dermatol. 2013;69(5):824-6. doi: 10.1016/j.jaad.2013.04.050
- Al Houssien AO, Al Houssien RO, Al Ajroush W, Al Kahtani HS. Chronic diseases among vitiligo patients. A case control study. Saudi Med J. 2017;38(4):400-4. doi: 10.15537/smj.2017.4.17551
- Bae J, Lee J, Yun J, et al. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. J Am Acad Dermatol. 2017;76(5):871-8. doi: 10.1016/j.jaad.2016.12.034
- Gopal KV, Rao G, Kumar Y. Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: A case-control study. Indian Dermatol Online J. 2014;5(4):456. doi: 10.4103/2229-5178.142493
- Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol. 1999;26(10):653-57. doi: 10.1111/j.1346-8138.1999.tb02067.x
- Korde S, Gugle A, Pawar M. A study of association of diabetes mellitus and vitiligo. MVP J Med Sci. 2018;5(2):125-33. doi: 10.18311/mvpjms/2018/v5i2/18265
- Kumar K, Priya S, Sharma R, et al. Autoimmune thyroid disease in patients with vitiligo: prevalence study in india. Endocr Pract. 2012;18(2):194-9. doi: 10.4158/EP11205.OR
- Nejad S, Goldust M, Qadim H, et al. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pak J Biol Sci. 2013;16(12):570-4. doi: 10.3923/pjbs.2013.570.574
- Poojary S. Vitiligo and associated autoimmune disorders: A retrospective hospital-based study in Mumbai, India. Allergol Immunopathol (Madr). 2011;39(6):356-61. doi: 10.1016/j.aller.2010.12.007
- Saleem K, Azim W. Association of vitiligo with other autoimmune disorders. Diabetes Case Rep. 2016;1(3). doi: 10.4172/2572-5629.1000114
- Sedighe M, Gholamhossein G. Thyroid dysfunction and thyroid antibodies in Iranian patiens with vitiligo. Indian J Dermatol. 2008;53(1):9-11. doi: 10.4103/0019-5154.39733
- Sivasubramanian A, Ganapathi S. The study on association of co-morbidities in female patients with vitiligo. Int J Res Dermatol. 2019;5(1):203. doi: 10.18203/issn.2455-4529
- Tanioka M, Yamamoto Y, Katoh M, et al. Vitiligo vulgaris and autoimmune diseases in Japan: a report from vitiligo clinic in Kyoto University Hospital. Dermatoendocrinol. 2009;1(1):43-5. doi: 10.4161/derm.1.1.7306
- Topal OI, Duman H, Gungor S, et al. Evaluation of the clinical and sociodemographic features of Turkish patients with vitiligo. Acta Dermatovenerol Croat. 2016;24(2):124-9. https://hrcak.srce.hr/161242
- Vachiramon V, Harnchoowong S, Onprasert W, Chanprapaph K. Prevalence of thyroid abnormalities in thai patients with vitiligo. Biomed Res Int. 2017;2017:1-6. doi: 10.1155/2017/7502935
- Yang Y, Huang G, Yan X, Qing Z. Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo. Indian J Dermatol. 2014;59(4):357. doi: 10.4103/0019-5154.135485
- Zhang Z, Xu S, Zhang F, et al. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients. Arch Dermatol Res. 2009;301(2):167-73. doi: 10.1007/s00403-008-0900-z
- Iacovelli P, Sinagra J, Vidolin A, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005;210(1):26-30. doi: 10.1159/000081479
- Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, et al. Increased prevalence of chronic autoimmune (Hashimoto’s) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol. 2005;53(2):220-3. doi: 10.1016/j.jaad.2005.03.032
- Kroon M, Vrijman C, Chandeck C, et al. High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo. Horm Res Paediatr.2013;79(3):137-44. doi: 10.1159/000348388
- Mazereeuw-Hautier J, Bezio S, Mahe E, et al. Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: A prospective observational study. J Am Acad Dermatol. 2010;62(6):945-9. doi: 10.1016/j.jaad.2009.06.081
- Prćić S, Djuran V, Katanić D, et al. Vitiligo and thyroid dysfunction in children and adolescents. Acta Dermatovenerol Croat. 2011;19(4):248-54.
- Cho S, Kim J, Cho S, et al. Vitiligo in children and adolescents: association with thyroid dysfunction. J Eur Acad Dermatol Venereol. 2011;25(1):64-7. doi: 10.1111/j.1468-3083.2010.03694.x
- Handa S, Dogra S. Epidemiology of childhood vitiligo: a study of 625 patients from North India. Pediatr Dermatol. 2003;20(3):207-10. doi: 10.1046/j.1525-1470.2003.20304.x
- Uncu S, Yaylı S, Bahadır S, et al. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol. 2011;50(2):175-9. doi: 10.1111/j.1365-4632.2010.04665.x
- Yang Y, Lin X, Fu W, et al. An approach to the correlation between vitiligo and autoimmune thyroiditis in Chinese children. Clin Exp Dermatol. 2010;35(7):706-10. doi: 10.1111/j.1365-2230.2009.03671.x
- Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010 Feb;123(2):183.e1-9. doi: 10.1016/j.amjmed.2009.06.030
- Ruggeri R, Trimarchi F, Giuffrida G, et al. Autoimmune comorbidities in Hashimoto’s thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol. 2017;176(2):133-41. doi: 10.1530/EJE-16-0737
- Prindaville B, Rivkees S. Incidence of vitiligo in children with Graves’ disease and Hashimoto’s thyroiditis. Int J Pediatr Endocrinol. 2011;2011(1):18. doi: 10.1186/1687-9856-2011-18
- Gong Q, Li X, Gong Q, et al. Hashimoto’s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases. Arch Dermatol Res. 2016;308(4):277-81. doi: 10.1007/s00403-016-1641-z
- Slominski A, Pisarchik A, Wortsman J, et al. Expression of hypothalamic–pituitary–thyroid axis related genes in the human skin. J Invest Dermatol. 2002;119(6):1449-55. doi: 10.1046/j.1523-1747.2002.19617.x
- Cianfarani F, Baldini E, Cavalli A, et al. TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol. 2010;130(1):93-101. doi: 10.1038/jid.2009.180
- Ferrari S, Fallahi P, Ruffilli I, et al. The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series. Autoimmun Rev. 2019;18(3):287-92. doi: 10.1016/j.autrev.2018.10.001
- Liu CW, Huang YC. Vitiligo and autoantibodies: a systematic review and meta-analysis. J Dtsch Dermatol Ges. 2018;16(7):845-51. doi: 10.1111/ddg.13574
- Lim HK, Bae MI, Jeong KH, et al. Positivity rates of antithyroid antibody, antinuclear antibody and thyroid peroxidase antibody in different types of vitiligo. Clin Exp Dermatol. 2016;41(3):242-7. doi: 10.1111/ced.12771
- Onunu A, Kubeyinje E. Vitiligo in the Nigerian African: a study of 351 patients in Benin City, Nigeria. Int J Dermatol. 2003;42(10):800-2. doi: 10.1046/j.1365-4362.2003.01908.x
- Nederstigt C, Uitbeijerse B, Janssen L, et al. Associated autoimmune disease in type 1 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol. 2019;180(2):135-44. doi: 10.1530/EJE-18-0515
- Afkhami-Ardekani M, Ghadiri-Anari A, Ebrahimzadeh-Ardakani M, Zaji N. Prevalence of vitiligo among type 2 diabetic patients in an Iranian population. Int J Dermatol. 2014;53(8):956-8. doi: 10.1111/ijd.12148
- Chang HC, Lin MH, Huang YC, Hou TY. The association between vitiligo and diabetes mellitus: A systematic review and meta-analysis. J Am Acad Dermatol. 2019;81(6):1442-5. doi: 10.1016/j.jaad.2019.06.022
- Farhan J, Al-Shobaili H, Zafar U, et al. Interleukin-6: a possible inflammatory link between vitiligo and type 1 diabetes. Br J Biomed Sci. 2014;71(4):151-7. doi: 10.1080/09674845.2014.11669980
- Meyer G, Neumann K, Badenhoop K, Linder R. Increasing prevalence of Addison’s disease in German females: health insurance data 2008–2012. Eur J Endocrinol. 2014;170(3):367-73. doi: 10.1530/EJE-13-0756
- Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol. 2004;137(2):225-33. doi: 10.1111/j.1365-2249.2004.02561.x
- Amerio P, Tracanna M, De Remigis P, et al. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B + C and 4. Clin Exp Dermatol. 2006;31(5):746-9. doi: 10.1111/j.1365-2230.2006.02171.x
- Amerio P, Di Rollo D, Carbone A, et al. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol. 2010;20(3):354-8. doi: 10.1684/ejd.2009.0939
- Dittmar M, Kahaly G. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab. 2003;88(7):2983-92. doi: 10.1210/jc.2002-021845
- Perheentupa J. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. J Clin Endocrinol Metab. 2006;91(8):2843-50. doi: 10.1210/jc.2005-2611
- Ferre E, Rose S, Rosenzweig S, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1(13):e88782. doi: 10.1172/jci.insight.88782
- Bruserud Ø, Oftedal B, Landegren N, et al. A Longitudinal follow-up of Autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2016;101(8):2975-83. doi: 10.1210/jc.2016-1821
- Туриев Г.С. Аутоиммунные заболевания у больных сахарным диабетом взрослых. Владикавказский медико-биологич. вестн. 2013;17(26):74-80 [Turiev GS. Autoimmune diseases in diabetes mellitus in adult patients. Vladikavkazskij mediko-biologich. vestn. 2013;17(26):74-80 (In Russ.)].
- Orlova EM, Sozaeva LS, Kareva MA, et al. Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2017;102(9):3546-56. doi: 10.1210/jc.2017-00139
- Ломоносов К.М., Симонова Н.И., Ломоносов М.К. Сравнительный анализ сывороточного содержания аутоантител у больных витилиго. Рос. журн. кожных и венерических болезней. 2013;2:35 [Lomonosov KM, Simonova NI, Lomonosov MK. Comparative analysis of serum autoantibodies in patients with vitiligo. Ros. zhurn. kozhnyh i venericheskih boleznej. 2013;2:35 (In Russ.)].